Xylem reaffirms FY25 adjusted EPS view $4.50-$4.70, consensus $4.63

Raises FY25 revenue view to $8.7B-$8.8B from %8.6B. Consensus is for FY25 revenue $8.74B. Revenue outlook represents an increase of 1%-2% on a reported basis, versus 0%-2% previously guided, and up approximately 3%-4% on an organic basis, in line with the previous guidance. Sees FY25 adjusted EBITDA margin 21.3%-21.8%, an increase of 70 to 120 basis points from Xylem’s (XYL) 2024 adjusted results. Sees FY25 free cash flow margin 9%-10%.